Form 144: Fastenal insider discloses $2.34M sale of 48,724 shares
Rhea-AI Filing Summary
Fastenal Co (FAST) disclosure reports a proposed sale of 48,724 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $2,341,201.51. The shares are part of 1,147,636,617 shares outstanding. The filing shows the shares were acquired and paid for by stock option exercise on 08/08/2025, with payment in cash. The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.
The notice states there were no securities sold in the past three months by the reporting person and includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notification of a single insider sale of 48,724 shares valued at $2.34M, executed via stock option exercise and routed through Morgan Stanley.
The filing documents a proposed sale under Rule 144 of 48,724 Fastenal shares with an aggregate value of $2,341,201.51. The shares were acquired and paid for by stock option exercise on 08/08/2025, and the transaction is to be handled by Morgan Stanley Smith Barney LLC on NASDAQ. The filing also reports no sales in the prior three months by the reporting person, which suggests this is an individual liquidity event rather than a pattern of disposals. The disclosure includes the required representation about lack of undisclosed material information.
TL;DR: Clean, complete Rule 144 notice showing an exercised option sale; procedural compliance appears met with broker and sale details provided.
The notice identifies the mechanics: shares were acquired via a stock option exercise and paid in cash, with the sale to be executed through Morgan Stanley Smith Barney LLC. It records the exact share count (48,724) and aggregate value ($2,341,201.51) and confirms nothing to report for sales in the prior three months. The form includes the statutory attestation that the seller is not aware of undisclosed material adverse information, satisfying typical Rule 144 attestation requirements for an insider sale.